Related Experiment Video
Updated: Aug 17, 2026
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Fontolizumab Protein Design Labs
1francisj_dumont@yahoo.com
Current Opinion in Investigational Drugs (London, England : 2000)
|May 26, 2005
Abstract:
Protein Design Labs is developing fontolizumab, a humanized anti-interferon gamma monoclonal antibody, for the potential treatment of autoimmune diseases. By February 2003, the company was actively seeking to outlicense the development and commercialization rights to fontolizumab outside of the US and Canada.
